• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Calidi Biotherapeutics, Inc. Common Stock (NY:CLDI)

1.170 -0.010 (-0.85%)
Streaming Delayed Price Updated: 2:09 PM EST, Jan 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 35,207
Open 1.220
Bid (Size) 1.170 (1,000)
Ask (Size) 1.180 (500)
Prev. Close 1.180
Today's Range 1.163 - 1.220
52wk Range 1.100 - 19.20
Shares Outstanding 7,167,721
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
New Approach Could Increase Response Rates for Cancer Immunotherapy
December 23, 2025
Via Investor Brand Network
Novel Biomarker Could Predict Resistance to Immunotherapy, Study Finds
December 17, 2025
Via Investor Brand Network

Performance

YTD
-0.8%
-0.8%
1 Month
-19.9%
-19.9%
3 Month
-25.0%
-25.0%
6 Month
-59.4%
-59.4%
1 Year
-92.2%
-92.2%

More News

Read More
Study Highlights Increasing Cases of Breast Cancer in Younger Women
December 12, 2025
Via Investor Brand Network
Study Proposes Overhaul of US Lung Cancer Screening Guidelines
December 08, 2025
Via Investor Brand Network
News headline image
Calidi Biotherapeutics and Nova Minerals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
December 05, 2025
Via ACCESS Newswire
Study Suggests mRNA Covid Vaccine Could Boost Cancer Immunotherapy
October 22, 2025
Via Investor Brand Network
Cancer Immunotherapy Could Be Boosted by Targeting Pathways of DNA Repair
December 04, 2025
Via Investor Brand Network
What Patients Need to Know About Exercising During Cancer Treatment
November 21, 2025
Via Investor Brand Network
Study identifies Biomarker to Predict Success of Immunotherapy, Chemo for Breast Cancer
November 19, 2025
Via Investor Brand Network
Rarest Natural Element Promises to Revolutionize How Cancer is Treated
November 13, 2025
Via Investor Brand Network
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
November 07, 2025
Via Benzinga
Cancer Immunotherapy Could Be Transformed by Boosting Natural Killer Cells
November 05, 2025
Via Investor Brand Network
Lung Cancer Screening is Still Woefully Low in the US, Report Shows
November 04, 2025
Via Investor Brand Network
Topics Death
New LED Therapy Kills Cancer Cells While Sparing Healthy Tissues
October 24, 2025
Via Investor Brand Network
Researchers Urge Canadians to Donate Toenails, for Science
October 16, 2025
Via Investor Brand Network
Researchers Discover Why Cancer Immunotherapy Could Be Failing
October 08, 2025
Via Investor Brand Network
Lund University Researchers Discover Why Leukemia Cells Evade the Immune System
October 07, 2025
Via Investor Brand Network
Researchers Find That Common Nutrient Could Supercharge the Immune Cells Fighting Cancer
September 25, 2025
Via Investor Brand Network
How Patients Can Boost Dietary Nutrient Intake During Cancer Treatment
September 17, 2025
Via Investor Brand Network
Study Finds That Common Sweetener Could Compromise Cancer Treatment Effectiveness
September 12, 2025
Via Investor Brand Network
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
September 04, 2025
Via Benzinga
TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) to Present at H.C. Wainwright Global Investment Conference
September 02, 2025
Via Investor Brand Network
New Study Discovers Unexpected Reason for Resistance to Cancer Immunotherapy
August 27, 2025
Via Investor Brand Network
TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Closes $6.9 Million Public Offering Including Full Over-Allotment Option
August 22, 2025
Via Investor Brand Network
Scientists Turn Bacteria into Trojan Horses to Deliver Anti-Cancer Viruses into Tumors
August 21, 2025
Via Investor Brand Network

Frequently Asked Questions

Is Calidi Biotherapeutics, Inc. Common Stock publicly traded?
Yes, Calidi Biotherapeutics, Inc. Common Stock is publicly traded.
What exchange does Calidi Biotherapeutics, Inc. Common Stock trade on?
Calidi Biotherapeutics, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Calidi Biotherapeutics, Inc. Common Stock?
The ticker symbol for Calidi Biotherapeutics, Inc. Common Stock is CLDI on the New York Stock Exchange
What is the current price of Calidi Biotherapeutics, Inc. Common Stock?
The current price of Calidi Biotherapeutics, Inc. Common Stock is 1.170
When was Calidi Biotherapeutics, Inc. Common Stock last traded?
The last trade of Calidi Biotherapeutics, Inc. Common Stock was at 01/05/26 02:09 PM ET
What is the market capitalization of Calidi Biotherapeutics, Inc. Common Stock?
The market capitalization of Calidi Biotherapeutics, Inc. Common Stock is 8.39M
How many shares of Calidi Biotherapeutics, Inc. Common Stock are outstanding?
Calidi Biotherapeutics, Inc. Common Stock has 8M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap